Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Poulam M. Patel, Christian H. Ottensmeier, Clive Mulatero, Paul Lorigan, Ruth Plummer, Hardev Pandha, Somaia Elsheikh, Efthymios Hadjimichael, Naty Villasanti, Sally E. Adams, Michelle Cunnell, Rachael L. Metheringham, Victoria A. Brentville, Lee Machado, Ian Daniels, Mohamed Gijon, Drew Hannaman & Lindy G. Durrant. (2018) Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial. OncoImmunology 7:6.
Read now
Read now
Stefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, Jonathan G. Pol, Laurence Zitvogel, Guido Kroemer, Andrea Facciabene & Lorenzo Galluzzi. (2017) Trial watch: DNA-based vaccines for oncological indications. OncoImmunology 6:12.
Read now
Read now
Wei Xue, Rachael L. Metheringham, Victoria A. Brentville, Barbara Gunn, Peter Symonds, Hideo Yagita, Judith M. Ramage & Lindy G. Durrant. (2016) SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade. OncoImmunology 5:6.
Read now
Read now
Lindy G Durrant, Victoria A Pudney & Ian Spendlove. (2011) Using monoclonal antibodies to stimulate antitumor cellular immunity. Expert Review of Vaccines 10:7, pages 1093-1106.
Read now
Read now
Lindy G Durrant, Victoria Pudney, Ian Spendlove & Rachael Louise Metheringham. (2010) Vaccines as early therapeutic interventions for cancer therapy: neutralising the immunosuppressive tumour environment and increasing T cell avidity may lead to improved responses. Expert Opinion on Biological Therapy 10:5, pages 735-748.
Read now
Read now
Articles from other publishers (23)
Divya Nagarajan, Joshua Pearson, Victoria Brentville, Rachael Metheringham, A Graham Pockley, Lindy Durrant & Stephanie E McArdle. (2021)
Helicase antigen (HAGE)‐derived vaccines induce immunity to HAGE and ImmunoBody®‐HAGE DNA vaccine delays the growth and metastasis of HAGE‐expressing tumors
in vivo
. Immunology & Cell Biology 99:9, pages 972-989.
Crossref
Crossref
Rukaia Almshayakhchi, Divya Nagarajan, Jayakumar Vadakekolathu, Barbara-Ann Guinn, Stephen Reeder, Victoria Brentville, Rachael Metheringham, A. Graham Pockley, Lindy Durrant & Stephanie McArdle. (2021) A Novel HAGE/WT1-ImmunoBody® Vaccine Combination Enhances Anti-Tumour Responses When Compared to Either Vaccine Alone. Frontiers in Oncology 11.
Crossref
Crossref
Samantha J. Paston, Victoria A. Brentville, Peter Symonds & Lindy G. Durrant. (2021) Cancer Vaccines, Adjuvants, and Delivery Systems. Frontiers in Immunology 12.
Crossref
Crossref
Stefania Cuzzubbo, Sara Mangsbo, Divya Nagarajan, Kinana Habra, Alan Graham Pockley & Stephanie E. B. McArdle. (2021) Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments. Frontiers in Immunology 11.
Crossref
Crossref
Peter L. Stern. 2021. Cancer Immunology. Cancer Immunology
413
432
.
Mireille Vankemmelbeke, Richard S. McIntosh, Jia Xin Chua, Thomas Kirk, Ian Daniels, Marilena Patsalidou, Robert Moss, Tina Parsons, David Scott, Gemma Harris, Judith M. Ramage, Ian Spendlove & Lindy G. Durrant. (2020) Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan–Targeting Antibodies without the Need for Immune Effector Cells or Complement. Cancer Research 80:16, pages 3399-3412.
Crossref
Crossref
Silvana T. Tivadar, Richard S. McIntosh, Jia Xin Chua, Robert Moss, Tina Parsons, Abed M. Zaitoun, Srinivasan Madhusudan, Lindy G. Durrant & Mireille Vankemmelbeke. (2020) Monoclonal Antibody Targeting Sialyl-di-Lewisa–Containing Internalizing and Noninternalizing Glycoproteins with Cancer Immunotherapy Development Potential. Molecular Cancer Therapeutics 19:3, pages 790-801.
Crossref
Crossref
Victoria A Brentville, Suha Atabani, Katherine Cook & Lindy G Durrant. (2018) Novel tumour antigens and the development of optimal vaccine design. Therapeutic Advances in Vaccines and Immunotherapy 6:2, pages 31-47.
Crossref
Crossref
Katherine Cook, Lindy Durrant & Victoria Brentville. (2018) Current Strategies to Enhance Anti-Tumour Immunity. Biomedicines 6:2, pages 37.
Crossref
Crossref
Faten A. M. Abo-Aziza, A. A. Zaki, A. El-Shemy, Sahar S. Abd Elhalem & Amany S. Amer. (2017) Immunological and histopathological changes in sheep affected with cutaneous squamous cell carcinoma and treated immunotherapeutically. Veterinary World 10:9, pages 1094-1103.
Crossref
Crossref
Peter L. Stern. (2017) Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12–13 May 2017. Therapeutic Advances in Vaccines 5:3, pages 55-68.
Crossref
Crossref
Wei Xue, Victoria A. Brentville, Peter Symonds, Katherine W. Cook, Hideo Yagita, Rachael L. Metheringham & Lindy G. Durrant. (2016) SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors. Oncotarget 7:50.
Crossref
Crossref
Victoria A. Brentville, Rachael L. Metheringham, Barbara Gunn, Peter Symonds, Ian Daniels, Mohamed Gijon, Katherine Cook, Wei Xue & Lindy G. Durrant. (2016) Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell–Mediated Antitumor Immunity. Cancer Research 76:3, pages 548-560.
Crossref
Crossref
Yu-Feng Xiao, Meng-Meng Jie, Bo-Sheng Li, Chang-Jiang Hu, Rui Xie, Bo Tang & Shi-Ming Yang. (2015) Peptide-Based Treatment: A Promising Cancer Therapy. Journal of Immunology Research 2015, pages 1-13.
Crossref
Crossref
Peter L. Stern. 2015. Cancer Immunology. Cancer Immunology
409
425
.
Jaimy M. S. Saif, Jayakumar Vadakekolathu, Shraddha S. Rane, Danielle McDonald, Murrium Ahmad, Morgan Mathieu, A. Graham Pockley, Lindy Durrant, Rachael Metheringham, Robert C. Rees & Stephanie E. B. McArdle. (2014) Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice. European Journal of Immunology 44:4, pages 994-1004.
Crossref
Crossref
Silvia Loureiro, Elena Robinson, Hongying Chen, Pongsathon Phapugrangkul, Camilo Colaco & Ian M Jones. 2012. Innovation in Vaccinology. Innovation in Vaccinology
45
63
.
Jing Xu, Xiao-Juan Zhu, Yu-Hua Li, Yang Dai, Yin-Chang Zhu, Jiang Zheng, Zhen-Qing Feng & Xiao-Hong Guan. (2011) Expression, characterization and therapeutic efficacy of chimeric Fab of anti-idiotypic antibody NP30 against Schistosoma japonicum. Acta Tropica 118:2, pages 159-164.
Crossref
Crossref
Silvia Loureiro, Junyuan Ren, Pongsathon Phapugrangkul, Camilo A. Colaco, Christopher R. Bailey, Holly Shelton, Eleonora Molesti, Nigel J. Temperton, Wendy S. Barclay & Ian M. Jones. (2011) Adjuvant-Free Immunization with Hemagglutinin-Fc Fusion Proteins as an Approach to Influenza Vaccines. Journal of Virology 85:6, pages 3010-3014.
Crossref
Crossref
Sanchayita Ghose, Justin Ladwig & Martin Allen. (2011) Comparison of the chromatographic properties of IgG1 and IgG2 antibody subclasses. Biotechnology and Applied Biochemistry 57:3, pages 111-116.
Crossref
Crossref
Victoria A. Pudney, Rachael L. Metheringham, Barbara Gunn, Ian Spendlove, Judith M. Ramage & Lindy G. Durrant. (2010)
DNA vaccination with T‐cell epitopes encoded within Ab molecules induces high‐avidity anti‐tumor CD8
+
T cells
. European Journal of Immunology 40:3, pages 899-910.
Crossref
Crossref
Grazziela P. Figueredo & Uwe Aickelin. 2010. Artificial Immune Systems. Artificial Immune Systems
4
17
.
Grazziela P. Figueredo & Uwe Aickelin. (2010) Defining a Simulation Strategy for Cancer Immunocompetence. SSRN Electronic Journal.
Crossref
Crossref